PUBLICATION
EVA1A (Eva-1 Homolog A) Promotes Endothelial Apoptosis and Inflammatory Activation Under Disturbed Flow Via Regulation of Autophagy
- Authors
- Canham, L., Sendac, S., Diagbouga, M.R., Wolodimeroff, E., Pirri, D., Tardajos Ayllon, B., Feng, S., Souilhol, C., Chico, T.J.A., Evans, P.C., Serbanovic-Canic, J.
- ID
- ZDB-PUB-230217-31
- Date
- 2023
- Source
- Arteriosclerosis, Thrombosis, and Vascular Biology 43(4): 547-561 (Journal)
- Registered Authors
- Chico, Tim J., Evans, Paul C., Serbanovic-Canic, Jovana
- Keywords
- apoptosis, atherosclerosis, autophagy, endothelial cell, zebrafish
- MeSH Terms
-
- Swine
- Humans
- Zebrafish*/genetics
- Atherosclerosis*/pathology
- Animals
- Apoptosis
- Mice
- Autophagy
- Endothelium/metabolism
- PubMed
- 36794585 Full text @ Arterio., Thromb., and Vas. Bio.
Citation
Canham, L., Sendac, S., Diagbouga, M.R., Wolodimeroff, E., Pirri, D., Tardajos Ayllon, B., Feng, S., Souilhol, C., Chico, T.J.A., Evans, P.C., Serbanovic-Canic, J. (2023) EVA1A (Eva-1 Homolog A) Promotes Endothelial Apoptosis and Inflammatory Activation Under Disturbed Flow Via Regulation of Autophagy. Arteriosclerosis, Thrombosis, and Vascular Biology. 43(4):547-561.
Abstract
Background Hemodynamic wall shear stress (WSS) exerted on the endothelium by flowing blood determines the spatial distribution of atherosclerotic lesions. Disturbed flow (DF) with a low WSS magnitude and reversing direction promotes atherosclerosis by regulating endothelial cell (EC) viability and function, whereas un-DF which is unidirectional and of high WSS magnitude is atheroprotective. Here, we study the role of EVA1A (eva-1 homolog A), a lysosome and endoplasmic reticulum-associated protein linked to autophagy and apoptosis, in WSS-regulated EC dysfunction.
Methods The effect of WSS on EVA1A expression was studied using porcine and mouse aortas and cultured human ECs exposed to flow. EVA1A was silenced in vitro in human ECs and in vivo in zebrafish using siRNA and morpholinos, respectively.
Results EVA1A was induced by proatherogenic DF at both mRNA and protein levels. EVA1A silencing resulted in decreased EC apoptosis, permeability, and expression of inflammatory markers under DF. Assessment of autophagic flux using the autolysosome inhibitor, bafilomycin coupled to the autophagy markers LC3-II and p62, revealed that EVA1A knockdown promotes autophagy when ECs are exposed to DF, but not un-DF . Blocking autophagic flux led to increased EC apoptosis in EVA1A-knockdown cells exposed to DF, suggesting that autophagy mediates the effects of DF on EC dysfunction. Mechanistically, EVA1A expression was regulated by flow direction via transcription factor TWIST1. In vivo, knockdown of EVA1A orthologue in zebrafish resulted in reduced EC apoptosis, confirming the proapoptotic role of EVA1A in the endothelium.
Conclusions We identified EVA1A as a novel flow-sensitive gene that mediates the effects of proatherogenic DF on EC dysfunction by regulating autophagy.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping